RUSSELL ALAN J (Chief Scientific Officer) sold 81.0% of their position (100K shares) of EDGEWISE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.11M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/13/2025ACC: 0001853529-25-000007
DirectorOfficer· Chief Scientific Officer
Since Mar 2021
-100K
Net shares
Net seller
$2.11M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
100K acquired · 200K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+100K
Price / share
$0.18
Trade value
$18K
% of position
427.4%
11/12/2025
23.40K→123.40K
Common Stock
Direct
Shares
−100K
Price / share
$21.12
Trade value
$2.11M
% of position
81.0%
11/12/2025
123.40K→23.40K
Total
Net shares
+0.00
Net value
-$2.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/12/2025 | M · Option Exercise | +100K | $0.18 | $18K | 427.4% | 23.40K | 123.40K |
| Common Stock Direct | 11/12/2025 | S · Sale | −100K | $21.12 | $2.11M | 81.0% | 123.40K | 23.40K |
| Total | +0.00 | -$2.09M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
100K shares
Shares
−100K
Strike price
0.18
Held after
1.15M
Exercisable
—
11/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock100K shares | 11/12/2025 | M · Option Exercise | −100K | 0.18 | — | 1.15M |